1. 127POutcomes based on albumin‐bilirubin (ALBI) grade in the phase III CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC). (24th November 2019) Authors: Chan, S L; Miksad, R; Cicin, I; Chen, Y; Klumpen, H J; Kim, S; Lin, Z Z; Youkstetter, J; Sen, S; Cheng, A-L; El-Khoueiry, A B; Meyer, T; Kelley, R K; Abou-Alfa, G K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1401PThe efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey. (23rd October 2018) Authors: Kilickap, S; Ölmez, Ö F; Cicin, I; Demirci, U; Alan, O; Cabuk, D; Şakalar, T; Tatlı, A M; Başol Buğdaycı, F; Eralp, Y; Uysal, M; Demirkazık, A; Bilgin, B; Yıldız, B; Karaağaç, M; Okutur, K; Sakin, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 325PPertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results. (23rd October 2018) Authors: Esin, E; Cakmak Oksuzoglu, O B; Bilici, A; Cicin, I; Aksoy, S; Alacacioglu, A; Kaplan, M A; Cabuk, D; Sumbul, A T; Paydas, S; Sakin, A; Er, Ö; Korkmaz, T; Yildirim, N; Artac, M; Harputluoglu, H; Yumuk, P F; Basaran, G; Oyan Uluc, B; Demirci, U Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 703PAssessment of disease burden in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC). (23rd October 2018) Authors: Blanc, J F; Meyer, T; Cheng, A-L; El-Khoueiry, A B; Cicin, I; Chen, Y; Bolondi, L; Dadduzio, V; Baron, A; Lin, Z-Z; Adriani, J; Kelly, R K; Abou-Alfa, G K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LBA62Health-related quality of life (HRQoL) for pembrolizumab or placebo plus carboplatin and paclitaxel or nab-paclitaxel in patients with metastatic squamous NSCLC: Data from KEYNOTE-407. (23rd October 2018) Authors: Mazières, J; Kowalski, D; Luft, A; Vicente, D; Tafreshi, A; Gümüş, M; Laktionov, K; Hermes, B; Cicin, I; Rodríguez-Cid, J; Wilson, J; Kato, T; Ramlau, R; Novello, S; Reddy, S; Piperdi, B; Li, X; Burke, T; Paz-Ares, L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. LBA9Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE). (24th November 2019) Authors: Kanesvaran, R; Biswas, B; Danchaivijitr, P; Lim, C S; Karabulut, B; Wong, Y F; Coskun, H S; Chang, C-H; Cicin, I; Ingles, S; Slimane, K; Erman, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. O-011Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC). (20th June 2018) Authors: Merle, P; Rimassa, L; Ryoo, B; Cicin, I; Harris, W; Banu, E; Sarker, D; Tan, B; Van Vlierberghe, H; Sen, S; Love, C; Cheng, A; Meyer, T; Kelley, R; Abou-Alfa, G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. O-022Outcomes based on Albumin‐Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC). (2nd July 2019) Authors: Miksad, R; Cicin, I; Chen, Y; Klumpen, H; Kim, S; Lin, Z; Youkstetter, J; Sen, S; Cheng, A; Meyer, T; Kelley, R; Abou-Alfa, G Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗